TD Cowen Initiates Coverage On Teva Pharmaceutical Indus with Buy Rating, Announces Price Target of $55

Benzinga Newsdesk www.benzinga.com Neutral 52.5%

Neg 0% Neu 52.5% Pos 0%

TD Cowen initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy rating and announces Price Target of $55.